Company intelligence / Profile preview

BlueWhale Bio

Philadelphia, Pennsylvania, United Statesbluewhale.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

BlueWhale Bio has not reported clinical results. The company’s focus remains on developing a next-generation platform to address bottlenecks in the manufacture of cell-based therapies, aiming for greater accessibility and lower costs

Therapeutic areas: Other
Modalities: Cell therapies (specific modalities such as CAR-T or TCR not explicitly stated but implied by founders' backgrounds and focus on cell therapy manufacturing)
Industry: Contract Manufacturing Organization

Partnerships

Danaher Ventures (lead investor and strategic partner through their Pioneer Program)University of Pennsylvania collaboration via scientific founders

Beyond the preview

Go deeper on BlueWhale Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BlueWhale Bio.

Explore the full profile